This article was originally published with an error in the “Treatment and follow-up” subsection of the results:
“In terms of pharmacological treatment, at the last follow-up visit, 7.9% of patients were on single pulmonary hypertension-specific treatment (mostly macitentan or sildenafil) and 20.6% were on combination pulmonary hypertension-specific treatment (mostly macitentan plus sildenafil) (table 3).”
has now been corrected to:
“In terms of pharmacological treatment, at the last follow-up visit, 29.7% of patients were on single pulmonary hypertension-specific treatment (mostly macitentan or sildenafil) and 20.6% were on combination pulmonary hypertension-specific treatment (mostly macitentan plus sildenafil) (table 3).”
in the article itself.
- Copyright ©ERS 2020
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.